News
As questions have arisen about whether the Bert Nash Center can meet future payrolls, a new report confirms the mental health ...
NORCROSS, Ga., June 10, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin-3 for patients with MASH cirrhosis and portal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results